© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 07, 2010
Gefitinib, an epidermal growth factor receptorâ€“tyrosine kinase inhibitor (EGFR-TKI), is commonly used as a treatment for nonâ€“small cell lung cancer (NSCLC).
Eyes with nAMD Treated with Ranibizumab Maintained Visual Acuity at SRF Resolution
Dietary Eliminations May Not Significantly Benefit Pediatric Eczema
Antibiotics to Treat Upper Respiratory Infections Increase Risk of C Difficile Infections